NEVANAC ophthalmic suspension is indicated for the treatment of pain and inflammation associated with cataract surgery. Reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients (see Pharmacology: Pharmacodynamics under Actions).